Showing results (521-530 of 665) with videos related to

Sort By:
Pageof 67
The Lancet. Rheumatology|March 28, 2026
Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort studyPiero Ruscitti, Tanja Stamm, Valentin Ritschl, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Annals of the Rheumatic Diseases|November 3, 2016
EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseasesHelen E Foster, Kirsten Minden, Daniel Clemente, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
European Urology Focus|October 6, 2020
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder CancerMarco Moschini, Luca Afferi, Giorgio Gandaglia, et al.
The Journal of Rheumatology|July 15, 2023
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III TrialsNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
The Journal of Urology|December 20, 2018
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic LevelAlp Tuna Beksac, Shivaram Cumarasamy, Ugo Falagario, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Nature Reviews. Urology|August 16, 2025
HER2 and urothelial carcinoma: current understanding and future directionsDaniele Raggi, Emanuele Crupi, Filippo Pederzoli, et al.
Pageof 67